Apo A1 interacts with LL-37, functioning as a scavenger at the endothelial cell level, thereby safeguarding the cells from its potentially deleterious effects—a mechanism that could potentially aid in the prevention of CVD linked to endothelial dysfunction [6,52] (Table 3). This evidence concerns the gene CAMP and endothelial dysfunction.